President Biden and Sen. Bernie Sanders (I-Vt.) have announced a joint initiative to address the cost cap for inhalers implemented by various pharmaceutical companies. The aim is to make these essential breathing devices more affordable for Americans.
In a letter, Sanders along with other Senate Democrats urged drug manufacturers to reassess the pricing of inhalers, which was significantly higher in the U.S. compared to what consumers in the United Kingdom were paying. This prompted calls for change as patients in the U.S. were paying as much as $645 per inhaler out-of-pocket, making it unaffordable for many Americans who rely on these devices for their health.
Moving forward, patients in the U.S. will not have to pay more than $35 out-of-pocket for an inhaler, making it more accessible to those who need them most. This is a significant step towards ensuring that all Americans can afford essential medications they need to stay healthy.
President Biden and Senator Sanders, along with health professionals, will be addressing the media at 11:00 a.m. EDT to discuss this initiative further. The live video of this event can be watched above
